001     167532
005     20240326154322.0
024 7 _ |a 10.1038/s41467-021-21297-y
|2 doi
024 7 _ |a pmid:33602930
|2 pmid
024 7 _ |a altmetric:100388269
|2 altmetric
037 _ _ |a DKFZ-2021-00397
041 _ _ |a eng
082 _ _ |a 500
100 1 _ |a Xydia, Maria
|0 P:(DE-He78)d3f0a48c15b355dfeae29fd5137d8bcb
|b 0
|e First author
245 _ _ |a Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients.
260 _ _ |a [London]
|c 2021
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1711463791_21797
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:D015#LA:D015#
520 _ _ |a Regulatory CD4+ T cells (Treg) prevent tumor clearance by conventional T cells (Tconv) comprising a major obstacle of cancer immune-surveillance. Hitherto, the mechanisms of Treg repertoire formation in human cancers remain largely unclear. Here, we analyze Treg clonal origin in breast cancer patients using T-Cell Receptor and single-cell transcriptome sequencing. While Treg in peripheral blood and breast tumors are clonally distinct, Tconv clones, including tumor-antigen reactive effectors (Teff), are detected in both compartments. Tumor-infiltrating CD4+ cells accumulate into distinct transcriptome clusters, including early activated Tconv, uncommitted Teff, Th1 Teff, suppressive Treg and pro-tumorigenic Treg. Trajectory analysis suggests early activated Tconv differentiation either into Th1 Teff or into suppressive and pro-tumorigenic Treg. Importantly, Tconv, activated Tconv and Treg share highly-expanded clones contributing up to 65% of intratumoral Treg. Here we show that Treg in human breast cancer may considerably stem from antigen-experienced Tconv converting into secondary induced Treg through intratumoral activation.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Rahbari, Raheleh
|0 0000-0002-1839-7785
|b 1
700 1 _ |a Ruggiero, Eliana
|0 P:(DE-He78)606957afb35b517e3fdd526379767c48
|b 2
700 1 _ |a Macaulay, Iain
|b 3
700 1 _ |a Tarabichi, Maxime
|b 4
700 1 _ |a Lohmayer, Robert
|b 5
700 1 _ |a Wilkening, Stefan
|0 P:(DE-He78)928f784868a4b5ff301367ecda92f152
|b 6
700 1 _ |a Michels, Tillmann
|b 7
700 1 _ |a Brown, Daniel
|b 8
700 1 _ |a Vanuytven, Sebastiaan
|b 9
700 1 _ |a Mastitskaya, Svetlana
|0 0000-0002-4819-2908
|b 10
700 1 _ |a Laidlaw, Sean
|0 0000-0001-7658-1428
|b 11
700 1 _ |a Grabe, Niels
|b 12
700 1 _ |a Pritsch, Maria
|0 P:(DE-HGF)0
|b 13
700 1 _ |a Fronza, Raffaele
|0 P:(DE-He78)c2585457f370249465a2080111937cf5
|b 14
700 1 _ |a Hexel, Klaus
|0 P:(DE-He78)8e8f777853496a781f0c651d77c36abf
|b 15
|u dkfz
700 1 _ |a Schmitt, Steffen
|0 P:(DE-He78)9743d171a21db4cf055df4dcf0153153
|b 16
|u dkfz
700 1 _ |a Müller-Steinhardt, Michael
|b 17
700 1 _ |a Halama, Niels
|b 18
700 1 _ |a Domschke, Christoph
|b 19
700 1 _ |a Schmidt, Manfred
|0 P:(DE-He78)b91bec47a4148ba68a58ab292d5860f2
|b 20
|u dkfz
700 1 _ |a von Kalle, Christof
|0 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de
|b 21
|u dkfz
700 1 _ |a Schütz, Florian
|b 22
700 1 _ |a Voet, Thierry
|b 23
700 1 _ |a Beckhove, Philipp
|0 P:(DE-He78)1732377f6242a18280bc6aaa196988d1
|b 24
|e Last author
773 _ _ |a 10.1038/s41467-021-21297-y
|g Vol. 12, no. 1, p. 1119
|0 PERI:(DE-600)2553671-0
|n 1
|p 1119
|t Nature Communications
|v 12
|y 2021
|x 2041-1723
909 C O |p VDB
|o oai:inrepo02.dkfz.de:167532
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)d3f0a48c15b355dfeae29fd5137d8bcb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)606957afb35b517e3fdd526379767c48
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)928f784868a4b5ff301367ecda92f152
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)c2585457f370249465a2080111937cf5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)8e8f777853496a781f0c651d77c36abf
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)9743d171a21db4cf055df4dcf0153153
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)b91bec47a4148ba68a58ab292d5860f2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)5bacb661d5d7c0220d8f996d980ad8de
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
913 0 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Functional and structural genomics
|x 0
914 1 _ |y 2021
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2018
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2020-08-25
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2020-08-25
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-08-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2020-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-08-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b NAT COMMUN : 2018
|d 2020-08-25
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2020-08-25
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-08-25
920 1 _ |0 I:(DE-He78)D015-20160331
|k D015
|l Translationale Immunologie
|x 0
920 1 _ |0 I:(DE-He78)W220-20160331
|k W220
|l Zytometrie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D015-20160331
980 _ _ |a I:(DE-He78)W220-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21